Emory University as of March 31, 2018
Portfolio Holdings for Emory University
Emory University holds 46 positions in its portfolio as reported in the March 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Berkshire Hathaway (BRK.A) | 25.0 | $35M | 117.00 | 299102.56 | |
| Jd (JD) | 3.6 | $5.0M | 125k | 40.49 | |
| Myovant Sciences | 2.7 | $3.8M | 176k | 21.27 | |
| Beigene (BGNE) | 2.3 | $3.2M | 19k | 168.02 | |
| Ascendis Pharma A S (ASND) | 2.2 | $3.1M | 47k | 65.39 | |
| Blueprint Medicines (BPMC) | 2.1 | $2.9M | 32k | 91.69 | |
| Kala Pharmaceuticals | 2.0 | $2.8M | 177k | 15.83 | |
| Avexis | 2.0 | $2.8M | 23k | 123.57 | |
| Puma Biotechnology (PBYI) | 1.9 | $2.7M | 39k | 68.04 | |
| Ablynx Nv | 1.9 | $2.6M | 48k | 54.55 | |
| Inflarx Nv (IFRX) | 1.9 | $2.6M | 91k | 28.84 | |
| Sage Therapeutics (SAGE) | 1.9 | $2.6M | 16k | 161.05 | |
| Amicus Therapeutics (FOLD) | 1.9 | $2.6M | 173k | 15.04 | |
| Retrophin | 1.8 | $2.6M | 115k | 22.36 | |
| Neurocrine Biosciences (NBIX) | 1.8 | $2.5M | 31k | 82.93 | |
| Zogenix | 1.8 | $2.5M | 64k | 40.05 | |
| Incyte Corporation (INCY) | 1.8 | $2.5M | 30k | 83.33 | |
| Alnylam Pharmaceuticals (ALNY) | 1.8 | $2.5M | 21k | 119.11 | |
| Seattle Genetics | 1.8 | $2.5M | 48k | 52.33 | |
| Aquinox Pharmaceuticals | 1.8 | $2.5M | 179k | 14.08 | |
| BioMarin Pharmaceutical (BMRN) | 1.8 | $2.5M | 31k | 81.08 | |
| Genomic Health | 1.8 | $2.5M | 80k | 31.28 | |
| Acceleron Pharma | 1.7 | $2.4M | 62k | 39.10 | |
| Alexion Pharmaceuticals | 1.7 | $2.4M | 22k | 111.46 | |
| Seagate Technology Com Stk | 1.7 | $2.4M | 41k | 58.52 | |
| Corium Intl | 1.7 | $2.4M | 211k | 11.47 | |
| Dicerna Pharmaceuticals | 1.7 | $2.4M | 246k | 9.56 | |
| Dbv Technologies S A (DBVT) | 1.7 | $2.3M | 101k | 23.07 | |
| La Jolla Pharmaceuticl Com Par | 1.6 | $2.3M | 77k | 29.78 | |
| Biohaven Pharmaceutical Holding | 1.6 | $2.3M | 89k | 25.76 | |
| Cbre Group Inc Cl A (CBRE) | 1.6 | $2.2M | 47k | 47.22 | |
| Microsoft Corporation (MSFT) | 1.5 | $2.1M | 24k | 91.26 | |
| Fox News | 1.5 | $2.1M | 57k | 36.37 | |
| Morgan Stanley (MS) | 1.5 | $2.1M | 39k | 53.97 | |
| Global Blood Therapeutics In | 1.4 | $2.0M | 42k | 48.31 | |
| Trinity Industries (TRN) | 1.4 | $2.0M | 61k | 32.63 | |
| Express Scripts Holding | 1.4 | $1.9M | 28k | 69.08 | |
| Armstrong World Industries (AWI) | 1.4 | $1.9M | 34k | 56.31 | |
| KKR & Co | 1.4 | $1.9M | 95k | 20.30 | |
| Wave Life Sciences (WVE) | 1.4 | $1.9M | 48k | 40.10 | |
| ACADIA Pharmaceuticals (ACAD) | 1.4 | $1.9M | 85k | 22.48 | |
| Alliance Data Systems Corporation (BFH) | 1.3 | $1.8M | 8.7k | 212.88 | |
| Summit Midstream Partners | 0.9 | $1.2M | 88k | 14.05 | |
| Cocrystal Pharma Inc Com Par | 0.7 | $910k | 153k | 5.95 | |
| Spdr S&p 500 Etf (SPY) | 0.2 | $229k | 872.00 | 262.61 | |
| Amazon (AMZN) | 0.2 | $229k | 158.00 | 1449.37 |
